Clinical radiotherapy audits in Belgium, 2011-2014

被引:7
|
作者
Scalliet, P. G. M. [1 ]
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, Serv Radiotherapie Oncol, B-1200 Brussels, Belgium
来源
CANCER RADIOTHERAPIE | 2015年 / 19卷 / 6-7期
关键词
Quality; Audit; Reporting;
D O I
10.1016/j.canrad.2015.05.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Systematic clinical radiotherapy audits have been introduced in Belgium in 2011, as part of the Federal Cancer Plan. This is in compliance with article 11 of the 97/43 Council directive of Euratom states, translated into the Belgian legislation by royal decree in 2002. The principle of clinical audits has thus been part of the federal legal requirements for more than 10 years. However, its application had to wait for the development of a practical approach: what authority will audit, who will be the auditors, along which methodology, at what frequency, etc. Since 2002, the Federal College of Radiotherapy has the mission to monitor quality of radiotherapy at large. It was therefore decided after discussions with the relevant administration at the Ministry of Health and the Federal Agency for Nuclear Control that the College would practically organise the audits. Early in the 2000s, the IAEA developed a manual for comprehensive audits, as a tool for quality improvement. Auditors were professionals of the domain and the audit visit took the form of a peer review. Great care was taken to assemble an audit party able to cover all aspects of clinical radiotherapy with a radiation oncologist, a medical physicist, a radiation therapist and, on demand, a quality officer. The IAEA manual contains a series of questionnaires to be prepared by the audited centre in advance (pre-audit and self-assessment), indicating what specific areas the auditors would assess. It is also a template for the auditors, ensuring that no area is left aside or forgotten during the site visit. The report, at the end of the visit, is drafted according to a specific report template, also developed by IAEA. Several members of the Belgian radiotherapy community have developed their auditor's skills by participating to the IAEA audit program; they are the core of the auditor Belgian team. 2015 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:621 / 623
页数:3
相关论文
共 50 条
  • [41] The National Tuberculosis Research Agenda in Peru, 2011-2014
    Yagui Moscoso, Martin
    Oswaldo Jave, Hector
    Curisinche Rojas, Maricela
    Gutierrez, Cesar
    Romani Romani, Franco
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2013, 33 (02): : 151 - 158
  • [42] Burden of Multiple Chronic Conditions in Delaware, 2011-2014
    Gupta, Sangeeta
    PREVENTING CHRONIC DISEASE, 2016, 13
  • [43] Recent Transmission of Tuberculosis - United States, 2011-2014
    Yuen, Courtney M.
    Kammerer, J. Steve
    Marks, Kala
    Navin, Thomas R.
    France, Anne Marie
    PLOS ONE, 2016, 11 (04):
  • [44] Mucoadhesive therapeutic compositions: a patent review (2011-2014)
    Laffleur, Flavia
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (03) : 377 - 388
  • [46] Results of Russian investigations into the middle atmosphere (2011-2014)
    Krivolutsky, A. A.
    Kukoleva, A. A.
    IZVESTIYA ATMOSPHERIC AND OCEANIC PHYSICS, 2016, 52 (05) : 497 - 511
  • [47] Attempted and Completed Suicide in Cuban Adolescents, 2011-2014
    Corona-Miranda, Beatriz
    Alfonso-Sague, Karen
    Hernandez-Sanchez, Mariela
    Cortes-Alfaro, Alba
    MEDICC REVIEW, 2018, 20 (01) : 36 - 41
  • [48] Russian investigations in the field of atmospheric radiation in 2011-2014
    Timofeev, Yu. M.
    Shul'gina, E. M.
    IZVESTIYA ATMOSPHERIC AND OCEANIC PHYSICS, 2016, 52 (05) : 467 - 482
  • [49] Influenza D Virus in Cattle,. France, 2011-2014
    Ducatez, Mariette F.
    Pelletier, Claire
    Meyer, Gilles
    EMERGING INFECTIOUS DISEASES, 2015, 21 (02) : 368 - 371
  • [50] Formulations of deoxycholic for therapy: a patent review (2011-2014)
    Hwang, Seung Rim
    Kim, In Jae
    Park, Jin Woo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (12) : 1423 - 1440